CYTOGEM 1GM – Composition, Uses and Medicine Enquiries
Product Overview
CYTOGEM 1GM is listed as a prescription product containing Gemcitabine (1000mg), marketed by Dr Reddy’s Laboratories Ltd. It belongs to the anticancer and nucleoside analog chemotherapy class and may be prescribed for selected pancreatic, lung, bladder, breast or ovarian cancers depending on the treatment protocol.
The active medicine interferes with DNA synthesis in dividing cancer cells.
Treatment suitability depends on the confirmed diagnosis, previous treatment, organ function and other medicines. The exact manufacturer pack, formulation, approved indication and administration schedule must be checked before treatment or publication.
A qualified clinician should assess suitability, interactions, contraindications and monitoring requirements. Blood counts, liver and kidney function and infusion-related toxicity require monitoring.
Composition and Strength
| Active Ingredient | Strength |
|---|---|
| Gemcitabine | 1000 mg (1 gm) |
Product Name: CYTOGEM 1GM
Generic Name: Gemcitabine
Brand Name: CYTOGEM 1GM
Strength: 1000 mg (1 gm)
Listed Marketer: Dr Reddy’s Laboratories Ltd
The exact formulation and product presentation should be verified against the original manufacturer packaging.
Therapeutic Category and Indication
CYTOGEM 1GM belongs to the anticancer medicine category and is classified as nucleoside analog chemotherapy.
It may be prescribed for selected pancreatic, lung, bladder, breast or ovarian cancers depending on the treatment protocol.
Gemcitabine works by interfering with DNA synthesis in dividing cancer cells.
The appropriate treatment protocol depends on the confirmed diagnosis, previous treatment, organ function and other medicines. The treating oncology specialist determines the benefit-risk balance and monitoring plan.
Administration Information
CYTOGEM 1GM is listed for intravenous infusion in a supervised oncology facility.
The treating clinician determines the appropriate administration schedule and monitoring requirements.
Patients should follow the approved product label and the oncology team’s instructions. They should not independently adjust the dose, skip safety monitoring or switch formulations without medical advice.
Product Presentation and Availability
The product enquiry can be made using the following details:
- Product Name: CYTOGEM 1GM
- Generic Name: Gemcitabine
- Strength: 1000 mg (1 gm)
- Therapeutic Category: Anticancer
- Medicine Class: Nucleoside Analog Chemotherapy
- Manufacturer Listed: Dr Reddy’s Laboratories Ltd
- Administration: Intravenous infusion
The exact dosage form, pack size, batch, storage, expiry and product-specific presentation must be verified from the original manufacturer packaging and an authorised provider.
Product details and supply eligibility may vary by country.
Prescription and Patient Safety
CYTOGEM 1GM is a prescription anticancer medicine that requires supervision by a qualified oncology specialist.
Treatment requires individual clinical assessment and appropriate monitoring.
Blood counts, liver and kidney function and infusion-related toxicity require monitoring. The treating specialist should assess potential interactions, contraindications and the patient’s overall clinical condition.
The exact precautions and monitoring requirements should be checked against the current approved product information.
Medicine Enquiry Coordination Through Medinglobal
Medinglobal is a healthcare coordination platform. It can receive medicine information requests and, where legally permissible, connect patients or institutions with appropriately authorised independent pharmaceutical providers.
Medinglobal does not itself sell, dispense, manufacture or export CYTOGEM 1GM.
Product availability, lawful supply, prescription validation, commercial terms and destination requirements must be verified by the independent provider. Submitting an enquiry does not guarantee fulfilment.
How to Submit a CYTOGEM 1GM Enquiry
To help identify the requested product, include the following details:
- Product or brand name: CYTOGEM 1GM.
- Generic name: Gemcitabine.
- Required strength and formulation.
- Required quantity.
- Destination country.
- Prescription or institutional documents, where required.
Medinglobal may coordinate an introduction to a suitably authorised provider, who independently verifies product details, regulatory eligibility and any transaction.
Frequently Asked Questions
What is CYTOGEM 1GM used for?
It may be used for selected pancreatic, lung, bladder, breast or ovarian cancers depending on the treatment protocol. The treating prescriber confirms the approved use.
What is the composition of CYTOGEM 1GM?
The supplied product information lists Gemcitabine 1000mg as its active ingredient.
How is CYTOGEM 1GM administered?
It is administered through intravenous infusion in a supervised oncology facility.
Which company markets CYTOGEM 1GM?
The supplied product catalogue lists Dr Reddy’s Laboratories Ltd.
What precautions are associated with CYTOGEM 1GM?
Blood counts, liver and kidney function and infusion-related toxicity require monitoring during treatment.
Can Medinglobal supply CYTOGEM 1GM directly?
No. Medinglobal coordinates medicine enquiries with independent authorised providers where legally permissible.



Reviews
There are no reviews yet.